Riot Platforms, Inc. earnings releases RIOT

Riot Platforms, Inc. last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $181.4 million (+0.7% year over year) and diluted EPS of $0.01. It usually reports 30–61 days after a quarter ends. Based on that pattern, the next release is estimated for around Mar 1, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 30–61 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 4, 2026
35 days after quarter end
Q3 FY2026
ended Sep 30, 2026
181
+0.7%
4
-96.1%
0.01
-96.2%
Aug 10, 2026
41 days after quarter end
Q2 FY2026
ended Jun 30, 2026
174
+13.9%
-237
-208.1%
-0.68
-217.2%
Apr 30, 2026
30 days after quarter end
Q1 FY2026
ended Mar 31, 2026
167
+3.6%
-500
-68.9%
-1.44
-60.0%
Mar 2, 2026
61 days after quarter end
Q4 FY2025
ended Dec 31, 2025
153
+7.2%
-691
-606.3%
-3.49
-1349.1%
Oct 30, 2025
30 days after quarter end
Q3 FY2025
ended Sep 30, 2025
180
+112.6%
104
+167.7%
0.26
+148.1%
Jul 31, 2025
31 days after quarter end
Q2 FY2025
ended Jun 30, 2025
153
+118.5%
219
+359.9%
0.58
+281.2%
May 1, 2025
31 days after quarter end
Q1 FY2025
ended Mar 31, 2025
161
+103.5%
-296
-239.9%
-0.90
-276.5%
Feb 24, 2025
55 days after quarter end
Q4 FY2024
ended Dec 31, 2024
143
+80.9%
136
+245.9%
0.28
+37.2%

Company profile

Industry
Finance Services (SIC 6199)
Listed as
RIOT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Castle Rock, CO
SEC filer status
Large accelerated filer
SEC CIK
1167419
Former names
Riot Blockchain, Inc. (until Dec 19, 2022); Bioptix, Inc. (until Sep 29, 2017); Venaxis, Inc. (until Nov 30, 2016); AspenBio Pharma, Inc. (until Dec 13, 2012); ASPENBIO INC (until Oct 31, 2005)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.